$1,001–$15,000Reported range · official band, not an exact amount
Held by the filer's dependent child per the disclosure. Disclosed 21 days after the transaction; reported as an official range, not an exact amount.
Traded Nov 11, 2025 · Filed Nov 13, 2025
The boss of Labcorp sold $1.51M of Labcorp shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,509,499
Shares × reported transaction price
14 days after results of Oct 28, 2025, 98 days before results of Feb 17, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $268.21 on Nov 11, 2025, 26% above its 52-week low and 8% below its high, after a 7% drop over the previous 30 trading days
52-week range $212.22 (Apr 21, 2025) to $290.93 (Oct 20, 2025), 71% of the way up, from 250 adjusted closes. 30 trading days earlier: $287.06 on Sep 30, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.5% | −1.9% | +1.4% |
| 30 days | −1.3% | +1.3% | −2.6% |
| 90 days | +4.2% | +1.4% | +2.8% |
| 180 days | −4.7% | +10.5% | −15.1% |
Past results only. Not a forecast.
Held by the filer's dependent child per the disclosure. Disclosed 21 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
Held by the filer's dependent child per the disclosure. Disclosed 6 days after the transaction; reported as an official range, not an exact amount.